These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 25622214)

  • 1. A web-based study of the relationship of duration of insulin pump infusion set use and fasting blood glucose level in adults with type 1 diabetes.
    Sampson Perrin AJ; Guzzetta RC; Miller KM; Foster NC; Lee A; Lee JM; Block JM; Beck RW;
    Diabetes Technol Ther; 2015 May; 17(5):307-10. PubMed ID: 25622214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of morning fasting blood glucose variability with insulin antibodies and clinical factors in type 1 diabetes.
    Yoneda C; Tashima-Horie K; Fukushima S; Saito S; Tanaka S; Haruki T; Ogino J; Suzuki Y; Hashimoto N
    Endocr J; 2016 Jul; 63(7):603-9. PubMed ID: 27170092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoring euglycemia in the basal state using continuous glucose monitoring in subjects with type 1 diabetes mellitus.
    Zisser HC; Bevier WC; Jovanovic L
    Diabetes Technol Ther; 2007 Dec; 9(6):509-15. PubMed ID: 18034605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying the impact of a short-interval interruption of insulin-pump infusion sets on glycemic excursions.
    Zisser H
    Diabetes Care; 2008 Feb; 31(2):238-9. PubMed ID: 18056889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated overnight closed-loop glucose control in young children with type 1 diabetes.
    Elleri D; Allen JM; Nodale M; Wilinska ME; Mangat JS; Larsen AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Technol Ther; 2011 Apr; 13(4):419-24. PubMed ID: 21355719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.
    Garg S; Brazg RL; Bailey TS; Buckingham BA; Slover RH; Klonoff DC; Shin J; Welsh JB; Kaufman FR
    Diabetes Technol Ther; 2012 Mar; 14(3):205-9. PubMed ID: 22316089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic Control and Factors Impacting Treatment Choice in Tubeless Insulin Pump Users: A Survey of the T1D Exchange Glu Online Community.
    Layne JE; Huyett LM; Ly TT
    J Diabetes Sci Technol; 2019 Nov; 13(6):1180-1181. PubMed ID: 31409136
    [No Abstract]   [Full Text] [Related]  

  • 8. Consequences of delayed pump infusion line change in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion.
    Thethi TK; Rao A; Kawji H; Mallik T; Yau CL; Christians U; Fonseca V
    J Diabetes Complications; 2010; 24(2):73-8. PubMed ID: 19395280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance and acceptability of a combined device for insulin infusion and glucose sensing in the home setting.
    Nørgaard K; Shin J; Welsh JB; Gjessing H
    J Diabetes Sci Technol; 2015 Mar; 9(2):215-20. PubMed ID: 25591857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin pump therapy in Moslem patients with type 1 diabetes during Ramadan fasting: an observational report.
    Benbarka MM; Khalil AB; Beshyah SA; Marjei S; Awad SA
    Diabetes Technol Ther; 2010 Apr; 12(4):287-90. PubMed ID: 20210567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
    Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
    Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
    Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
    Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The number of basal rates required to achieve near-normal basal glucose control in pump-treated type 2 diabetes.
    King AB; Clark D; Wolfe GS
    Diabetes Technol Ther; 2012 Oct; 14(10):900-3. PubMed ID: 22845649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calculating the insulin to carbohydrate ratio using the hyperinsulinaemic-euglycaemic clamp-a novel use for a proven technique.
    Bevier WC; Zisser H; Palerm CC; Finan DA; Seborg DE; Doyle FJ; Wollitzer AO; Jovanovic L
    Diabetes Metab Res Rev; 2007 Sep; 23(6):472-8. PubMed ID: 17315240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access of children and adolescents with type 1 diabetes to insulin pump therapy has greatly increased in France since 2001.
    Sulmont V; Lassmann-Vague V; Guerci B; Hanaire H; Leblanc H; Leutenegger E; Mihaileanu M; Tubiana-Rufi N;
    Diabetes Metab; 2011 Feb; 37(1):59-63. PubMed ID: 21147014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic control after 6 days of insulin pump reservoir use in type 1 diabetes: results of double-blind and open-label cross-over trials of insulin lispro and insulin aspart.
    Tamborlane WV; Renard E; Wadwa RP; Blevins T; Jacober SJ; Liu R; D'Souza DN; Rees TM
    J Diabetes; 2015 Mar; 7(2):270-8. PubMed ID: 24734891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial.
    Tumminia A; Crimi S; Sciacca L; Buscema M; Frittitta L; Squatrito S; Vigneri R; Tomaselli L
    Diabetes Metab Res Rev; 2015 Jan; 31(1):61-8. PubMed ID: 24816997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes.
    Karlin AW; Ly TT; Pyle L; Forlenza GP; Messer L; Wadwa RP; DeSalvo DJ; Payne SL; Hanes S; Clinton P; Maahs DM; Buckingham B
    Diabetes Technol Ther; 2016 Jul; 18(7):429-35. PubMed ID: 27227290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Benefits of Structured Optimization and Sensor-Augmented Insulin Pump Therapy in Adults With Type 1 Diabetes.
    Leelarathna L; Thabit H; Hartnell S; Willinska ME; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Evans ML; Arnolds S; Pieber TR; Hovorka R;
    J Diabetes Sci Technol; 2017 Jan; 11(1):180-181. PubMed ID: 27328806
    [No Abstract]   [Full Text] [Related]  

  • 20. The U.K. service level audit of insulin pump therapy in adults.
    White HD; Goenka N; Furlong NJ; Saunders S; Morrison G; Langridge P; Paul P; Ghatak A; Weston PJ
    Diabet Med; 2014 Apr; 31(4):412-8. PubMed ID: 24117515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.